Skip to main content

The Globe and Mail

Canadian pot stocks surge on new U.S. ETF, California legalization

Medical marijuana plants are pictured in this file photo

Dave Chan/The Globe and Mail

Canadian cannabis stocks surged to new records on Wednesday as investors enthused over early growth of the first U.S.-listed exchange-traded fund focused on the pot industry and the Jan. 1 legalization of recreational marijuana in California.

Cannabis producers Canopy Growth Corp and Aphria Inc were among the biggest gainers on the Toronto Stock Exchange's S&P/TSX composite index, surging as much as 11.9 per cent and 8.8 per cent respectively, although they later pared some of those gains. Aurora Cannabis, Canada's second-biggest listed producer, closed up 20 per cent. All hit record highs.

MJIC Inc's equal-weighted Canadian Marijuana Index, which tracks stocks of major cannabis companies, also hit a record and rose more than 14 per cent. [https://marijuanaindex.com/stock-quotes/canadian-marijuana-index/ ].

Story continues below advertisement

Canada's Horizons Marijuana Life Sciences ETF gained 10 per cent. The U.S.-listed ETFMG Alternative Harvest ETF , which began trading on Dec. 26, has risen to $164-million in net assets from $6-million in one week, according to Vahan Ajamian, an analyst at Beacon Securities in Toronto. Top Alternative Harvest holdings include Canadian weed producers Cronos Group Inc and Canopy.

"If Americans want to buy Canadian stocks in an easy way, this is the first ETF that provides that ability in the U.S.," Chris Damas, editor of the BCMI Cannabis Report, said in an interview.

Still, he cautioned that in his view the sector was in a bubble as foreigners were rushing to invest in the Canadian cannabis sector, causing demand to far outstrip supply.

Reports of long lines and product shortages in California, which legalized pot sales on Jan. 1, also helped the rally. Some investors see the launch of sales in Canada as a harbinger of what can be expected when Canada launches recreational sales in mid-2018.

To be sure, the only Canadian company with significant exposure to the California market is CannaRoyalty Corp, Ajamian said by email.

MJIC Vice-President Dan Nicholls said he expects a correction in the sector, given the steep gains.

"We saw a dramatic rise in trading volumes in the U.S. and Canada over the last week," he said. "This ... was likely tied directly to the California legalization as there has been little news of significance out of Canada during this time period."

Story continues below advertisement

"Many investors likely invest in Canadian stocks given its better cannabis regulatory climate compared to the U.S. and expanding international opportunities," Nicholls added.

Report an error
As of December 20, 2017, we have temporarily removed commenting from our articles as we switch to a new provider. We are behind schedule, but we are still working hard to bring you a new commenting system as soon as possible. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.